• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

July 9, 2018
Company Drug/Device Medical Condition Status
Prana Biotechnology Ltd PBT434 Parkinsonian diseases Phase I trial initiated
Poxel SA Imeglimin Metabolic diseases, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) Phase III trial initiated enrolling 403 subjects in the U.S.
Cellerant Therapeutics, Inc. romyelocel-L (human myeloid progenitor cells) serious bacterial and fungal infections in patients with de novo acute myeloid leukemia (AML) undergoing induction chemotherapy RMAT designation granted by the FDA
Merck & Company KEYTRUDA in combination with carboplatin-paclitaxel or nab-paclitaxel First-line treatment for metastatic squamous non-small cell lung cancer (NSCLC) Priority Review granted for sBLA by the FDA
Merz Neurosciences Xeomin (incobotulinumtoxinA) chronic drooling in adults with neurodegenerative diseases sBLA approved by the FDA
Compugen Ltd COM701 (first-in-class immunioncology therapeutic antibody targeting PVRIG in patients advanced solid tumors IND clearance granted by the FDA
Elite Pharmaceuticals, Inc. generic Percocet (Oxycodone Hydrochloride and Acetaminophen, USP CII) management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate aNDA approval granted by the FDA
Acadia Pharmaceuticals Inc. NUPLAZID (pimavanserin) capsule Parkinson’s disease psychosis Approval granted by the FDA
Pulmonx Inc. Zephyr Endobronchial Valve (Zephyr Valve) severe emphysema Approval granted by the FDA
Dermira Qbrexza excessive underarm sweating due to primary axillary hyperhidrosis Approval granted by the FDA
ReCor Medical Paradise Ultrasound Denervation System treatment of Hypertension Approval granted by the FDA
Alkermes plc Aristada Initio (aripiprazole lauroxil) schizophrenia in adults Approval granted by the FDA

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing